ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Trials Listed

June 25, 2010

MSK Starts Ovarian Cancer Program

November 21, 1986

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

NIH director would have broad authority over institute budgets in proposed bill.

July 22, 2005

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004